Skip to main content

Advertisement

Log in

The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey—Two Centers Study

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Purpose

Primary immunodeficiency diseases (PIDs) are inherited disorders of the immune system resulting in increased susceptibility to unusual infections and predisposition to autoimmunity and malignancies. The European Society for Immunodeficiencies (ESID) has developed an internet-based database for clinical and research data on patients with PID. This study aimed to provide a minimum estimate of the prevalence of each disorder and to determine the clinical characteristics and outcomes of patients with PID in Turkey.

Methods

Clinical features of 1435 patients with primary immunodeficiency disorders are registered in ESID Online Patient Registry by the Pediatric Immunology Departments of the Medical Faculties of Uludag University and Ege University Between 2004 and 2010. These two centers are the major contributors reporting PID patients to ESID database from Turkey.

Results

Predominantly antibody immunodeficiency (73.5 %) was the most common category followed by autoinflammatory disorders (13.3 %), other well defined immunodeficiencies (5.5 %), congenital defects of phagocyte number, function or both 3.5 %), combined T and B cell immunodeficiencies (2 %), defects in innate immunity (1 %), and diseases of immune dysregulation (0.7 %). Patients between 0 and 18 years of age constitued 94 % of total and the mean age was 9.2 ± 6 years. The consanguinity rate within the registered patients was 14.3 % (188 of 1130 patients). The prevalance of all PID cases ascertained from the registry was 30.5/100.000. The major cause of the mortality was severe infection which was seen in forty-two of seventy five deceased patients. The highest mortality was observed in patients with severe combined immunodeficiencies and ataxia-telangiectasia.

Conclusion

Promoting the awareness of PID among the medical professionals and the general public is required if premature death and serious morbidity occurs due to late diagnosis of the wider spectrum of PID are to be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Samarghitean C, Väliaho J, Vihinen M. IDR knowledge base for primary immunodeficiencies. Immunome Res. 2007;3:6.

    Article  PubMed  Google Scholar 

  2. Guzman D, Veit D, Knerr V, Kindle G, Gathmann B, Eades-Perner AM. The ESID Online Database network. Bioinformatics. 2007;23:654–55.

    Article  PubMed  CAS  Google Scholar 

  3. Marodi L, Notarangelo LD. Immunological and genetic bases of new primary immunodeficiencies. Nat Rev Immunol. 2007;7:851–61.

    Article  PubMed  CAS  Google Scholar 

  4. Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776–94.

    Article  PubMed  Google Scholar 

  5. Baumgart KW, Britton WJ, Kemp A, French M, Roberton D. The spectrum of primary immunodeficiency disorders in Australia. J Allergy Clin Immunol. 1997;100:415–23.

    Article  PubMed  CAS  Google Scholar 

  6. Golan H, Dalal I, Garty B, Schlesinger M, Levy J, Handzel Z, et al. The incidence of primary immunodeficiency syndromes in Israel. IMAJ. 2002;4(Suppl):S868–71.

    Google Scholar 

  7. Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol. 2006;26:519–32.

    Article  PubMed  Google Scholar 

  8. Al-Herz W. Primary immunodeficiency disorders in Kuwait: First report from Kuwait national primary immunodeficiency registry. J Clin Immunol. 2008;28:186–93.

    Article  PubMed  Google Scholar 

  9. Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol. 2007;27:517–24.

    Article  PubMed  CAS  Google Scholar 

  10. Shabestari MS, Maljaei SH, Baradaran R, Barzegar M, Hashemi F, Mesri A, et al. Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran. J Clin Immunol. 2007;27:510–6.

    Article  PubMed  Google Scholar 

  11. Stray-Pedersen A, Abrahamsen T, Froland S. Primary immunodeficiency diseases in Norway. J Clin Immunol. 2000;20:477–85.

    Article  PubMed  CAS  Google Scholar 

  12. Matamoros Flori N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G. Primary immunodeficiency syndrome in Spain: First report of the national registry in children and adults. J Clin Immunol. 1997;17:333–9.

    Article  PubMed  CAS  Google Scholar 

  13. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: A single-center study. J Clin Immunol. 2009;29:343–51.

    Article  PubMed  Google Scholar 

  14. Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27:497–502.

    Article  PubMed  CAS  Google Scholar 

  15. Gathmann B, Grimbacher B, Beauté J, Dudoit Y, Mahlaoui N, Fischer A. ESID Registry Working Party. The European internet-based patient and research database for primary immunodeficiencies: results 2006–2008. Clin Exp Immunol. 2009;157(1):3–11.

    Article  PubMed  Google Scholar 

  16. The European Society for Immunodeficiencies: http://www.esid.org/statistics.php (2011).

  17. Turkish Statistical Institute web site http://tuikapp.tuik.gov.tr/adnksdagitapp/adnks.zul

  18. CEREDIH: The French PID study group. The French national registry of primary immunodeficiency diseases. Clin Immunol. 2010;135:264–72.

    Article  Google Scholar 

  19. Abuzakouk M, Feighery C. Primary immunodeficiency disorders in the Republic of Ireland: First report of the national registry in children and adults. J Clin Immunol. 2005;25:73–7.

    Article  PubMed  CAS  Google Scholar 

  20. Modell V, Gee B, Lewis DB, Orange JS, Roifman CM, Routes JM, et al. Global study of primary immunodeficiency diseases (PI)–diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res. 2011;51:61–70.

    Article  PubMed  Google Scholar 

  21. Report of a WHO scientific group. Primary immunodeficiency diseases. Clin Exp Immunol. 1997;109(1):1–28.

    Article  Google Scholar 

  22. Savic S, Dickie LJ, Battellino M, McDermott MF. Familial Mediterranean fever and related periodic fever syndromes/autoinflammatory diseases. Curr Opin Rheumatol. 2012;24:103–12.

    Article  PubMed  CAS  Google Scholar 

  23. Naidoo R, Ungerer L, Cooper M, Pienaar S, Eley BS. Primary immunodeficiencies: A 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol. 2011;31:99–105.

    Article  PubMed  Google Scholar 

  24. Benjasupattananan P, Simasathein T, Vichyanond P, Leungwedchakarn V, Visitsunthorn N, Pacharn P, et al. Clinical characteristics and outcomes of primary immunodeficiencies in Thai children: an 18-year experience from a tertiary care center. J Clin Immunol. 2009;29:357–64.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We are thankful to Benjamin Gathmann for his help on providing access to our ESID registry data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sara S. Kilic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kilic, S.S., Ozel, M., Hafizoglu, D. et al. The Prevalances and Patient Characteristics of Primary Immunodeficiency Diseases in Turkey—Two Centers Study. J Clin Immunol 33, 74–83 (2013). https://doi.org/10.1007/s10875-012-9763-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9763-3

Keywords

Navigation